Sugi Predict

Sugi Predict / Compounds / SCHEMBL368490

SCHEMBL368490

SCHEMBL368490

COc1ccc(-n2/c(=N\C#N)n(C)c3cnc4ccc(-c5cccc(O)c5)cc4c32)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 2/20 0.45
▸ HSD17B2 P37059 2/20 0.45
▸ MTOR P42345 13/20 0.43
▸ PIK3CA P42336 11/20 0.43
▸ ATM Q13315 8/20 0.43
▸ ATR Q13535 4/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ PIK3CD O00329 7/20 0.42
▸ PIK3CB P42338 6/20 0.42
▸ PIK3CG P48736 6/20 0.42
▸ PIK3C3 Q8NEB9 2/20 0.42
▸ CSNK2A2 P19784 1/20 0.42
▸ FECH P22830 1/20 0.42
▸ CLK1 P49759 1/20 0.42
▸ GSK3A P49840 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ MELK Q14680 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368491 1.00 HSD17B1 (0.45) HSD17B1HSD17B2MTORPIK3CAATM
SCHEMBL367657 0.92 MTOR (0.46) MTORPIK3CAATMATRPIK3CD
SCHEMBL367658 0.92 MTOR (0.46) MTORPIK3CAATMATRPIK3CD
SCHEMBL367988 0.91 MTOR (0.47) MTORPIK3CAATMATRPIK3CD
SCHEMBL367987 0.91 MTOR (0.47) MTORPIK3CAATMATRPIK3CD
SCHEMBL367489 0.91 MTOR (0.43) MTORPIK3CAATMATRPIK3CD
SCHEMBL367285 0.91 MTOR (0.47) MTORPIK3CAATMATRCYP1A2
SCHEMBL367490 0.91 MTOR (0.43) MTORPIK3CAATMATRPIK3CD
SCHEMBL367284 0.91 MTOR (0.47) MTORPIK3CAATMATRCYP1A2
SCHEMBL14914548 0.90 MTOR (0.50) MTORPIK3CAATMATRPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593450-A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS Piramal Enterprises Limited (IN) 2013-05-22 — — EP claimed
US-20130116248-A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS Piramal Enterprises Limited (IN) 2013-05-09 — — US claimed
WO-2012007926-A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED (IN) 2012-01-19 — — WO claimed
US-9062046-B2 Substituted imidazoquinoline derivatives as kinase inhibitors Piramal Enterprises Limited (IN) 2015-06-23 — — US disclosed
EP-2593450-A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS Piramal Enterprises Limited (IN) 2013-05-22 — — EP disclosed
US-20130116248-A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS Piramal Enterprises Limited (IN) 2013-05-09 — — US disclosed
WO-2012007926-A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED (IN) 2012-01-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116248-A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS CDK2, CDK4, MAP3K1 HSD17B1 3364/4885HSD17B2 3486/4885MTOR 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.